Vinpocetine

Last updated
Vinpocetine
Vinpocetine.svg
Vinpocetine ball-and-stick.png
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy
category
  • Not recommended [1]
Routes of
administration 		Oral, intravenous
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability 56.6 ± 8.9%
Metabolism hepatic
Elimination half-life 2.54 ± 0.48 hours
Excretion renal
Identifiers
  • (3α,16α)-Eburnamenine-14-carboxylic acid ethyl ester
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.050.917 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C22H26N2O2
Molar mass 350.462 g·mol−1
3D model (JSmol)
  • O=C(OCC)C=4n1c3c(c2ccccc12)CCN5[C@H]3[C@](C=4)(CCC5)CC
  • InChI=1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1 Yes check.svgY
  • Key:DDNCQMVWWZOMLN-IRLDBZIGSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Vinpocetine (ethyl apovincaminate) is a synthetic derivative of the vinca alkaloid vincamine, differing by the removal of a hydroxyl group and by being the ethyl rather than the methyl ester of the underlying carboxylic acid. Vincamine is extracted from either the seeds of Voacanga africana or the leaves of Vinca minor (lesser periwinkle).

Contents

Medical uses

Vinpocetine has been used in many Asian and European countries for treatment of cerebrovascular disorders such as stroke and dementia for over three decades. [3]

The FDA has tentatively ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, is ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act. [4] [5] [6] [7] Despite this, vinpocetine remains widely available in dietary supplements often marketed as nootropics. [8] [9] [10] [11]

Vinpocetine does not fully support a benefit in either dementia or stroke. [12] [9] [13] As of 2003, three controlled clinical trials had tested "older adults with memory problems". [14]

Side effects

Use during pregnancy may harm the baby or result in miscarriage. [1]

Adverse effects of vinpocetine include flushing, nausea, dizziness, dry mouth, transient hypo- and hyper-tension, headaches, heartburn, and decreased blood pressure. [8] [15] FDA issued a statement in 2019 warning that "vinpocetine may cause a miscarriage or harm fetal development". [16]

Mechanism of action

Vinpocetine’s mechanism of action has been postulated to involve three potential effects: blockage of sodium channels, reduction of cellular calcium influx, and antioxidant activity. [13] Studies have also suggested that vinpocetine can inhibit PDE-1 in isolated rabbit aorta; [17] inhibit IKK in vitro, preventing IκB degradation and the following translocation of NF-κB to the cell nucleus; [18] [19] and increase DOPAC, a metabolic breakdown product of dopamine, in isolated striatal nerve endings of rats. [20]

Dietary supplement

The inclusion of vinpocetine in dietary supplements in the U.S. has come under scrutiny due to the lack of defined dosage parameters, unproven short- and long-term benefits, and risks to human health. [21] In the U.S., vinpocetine supplements are marketed as sports supplements, brain enhancers, and weight loss supplements. [9]

A 2015 analysis of 23 brands of vinpocetine dietary supplements sold at GNC and Vitamin Shoppe retail stores reported widespread labeling errors. [4] Only 6 of the 23 supplement labels (26%) provided consumers with accurate dosages of vinpocetine (ranging from 0.3 to 32 mg per recommended daily serving), while 6 of 23 (26%) contained no vinpocetine at all, despite their labels claiming that the ingredient was in them. [9] [8] In total, 9 of the 23 products tested were mislabeled, and 17 of 23 (74%) did not provide any information on the quantity of vinpocetine. [8]

In response to the study, then-senator Claire McCaskill, while at the time serving as the top Democrat on the Senate Special Committee on Aging, urged the FDA to suspend sales of vinpocetine supplements and asked 10 retailers to voluntarily stop selling vinpocetine products. McCaskill stated: "The way we regulate these supplements isn’t working—and it’s putting the lives and well-being of consumers at risk. We’ve seen products with false labels, tainted ingredients, wildly illegal claims, and, now, products containing synthesized ingredients that are classified as prescription drugs in other countries." [11]

Lawsuits

Procera AVH is a dietary supplement containing undisclosed amounts of vinpocetine in combination with huperzine A and acetyl-l-carnitine. [22] [23] In 2012, manufacturer Brain Research Labs (BRL) agreed to pay $500,000 to settle a class action lawsuit which alleged that the company had falsely marketed Procera AVH as capable of improving brain function, in violation of the Consumer Fraud Act. [24]

In July 2015, the U.S. Federal Trade Commission (FTC) ruled that marketing claims for Procera AVH, which promoted the product as a “solution” to memory loss and cognitive decline, were false, misleading, unsubstantiated, and in violation of the FTC Act. [24] [10] [25] [26] BRL and its affiliated companies Brain Power Partners, Brain Power Founders, and MedHealth Direct (all based in Laguna Beach, California) were fined $91 million. KeyView Labs, the Tampa, Florida-based company that purchased BRL in 2012, was fined $61 million. [24] [25] [10] [26] Also named in the FTC complaint were George Reynolds (aka Josh Reynolds), founder and chief science officer of BRL, and John Arnold, the sole officer and employee of MedHealth. The FTC complaint charged Reynolds with making deceptive expert endorsements for Procera AVH. [22] [24] [25] [10] [26] The defendants in the case ultimately agreed to pay $1.4 million to settle the allegations of deceptive advertising brought by the FTC and California law enforcement officials. In addition, a permanent injunction barred the defendants from making similar deceptive claims about Procera AVH in the future and from misrepresenting the existence, results, or conclusions of any scientific study. [25] [10]

Related Research Articles

<span class="mw-page-title-main">Dietary supplement</span> Product providing additional nutrients

A dietary supplement is a manufactured product intended to supplement a person's diet by taking a pill, capsule, tablet, powder, or liquid. A supplement can provide nutrients either extracted from food sources, or that are synthetic. The classes of nutrient compounds in supplements include vitamins, minerals, fiber, fatty acids, and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, and so are not nutrients per se, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, such as collagen from chickens or fish for example. These are also sold individually and in combination, and may be combined with nutrient ingredients. The European Commission has also established harmonized rules to help insure that food supplements are safe and appropriately labeled.

<span class="mw-page-title-main">Curcumin</span> Principal curcuminoid of turmeric

Curcumin is a bright yellow chemical produced by plants of the Curcuma longa species. It is the principal curcuminoid of turmeric, a member of the ginger family, Zingiberaceae. It is sold as a herbal supplement, cosmetics ingredient, food flavoring, and food coloring.

<span class="mw-page-title-main">Herbal medicine</span> Study and use of supposed medicinal properties of plants

Herbal medicine is the study of pharmacognosy and the use of medicinal plants, which are a basis of traditional medicine. With worldwide research into pharmacology, some herbal medicines have been translated into modern remedies, such as the anti-malarial group of drugs called artemisinin isolated from Artemisia annua, a herb that was known in Chinese medicine to treat fever. There is limited scientific evidence for the safety and efficacy of many plants used in 21st-century herbalism, which generally does not provide standards for purity or dosage. The scope of herbal medicine sometimes include fungal and bee products, as well as minerals, shells and certain animal parts.

<span class="mw-page-title-main">Nootropic</span> Compound intended to improve cognitive function

Nootropics, colloquially brain supplements, smart drugs and cognitive enhancers, are natural, semisynthetic or synthetic compounds which purportedly improve cognitive functions, such as executive functions, attention or memory.

<span class="mw-page-title-main">Piracetam</span> Chemical compound

Piracetam is a drug that has efficacy in cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia; sources differ on its usefulness for dementia. Piracetam is sold as a medication in many European countries. Sale of piracetam is not illegal in the United States, although it is not regulated nor approved by the FDA, so it is legally sold for research use only.

<span class="mw-page-title-main">Galantamine</span> Neurological medication

Galantamine is used for the treatment of cognitive decline in mild to moderate Alzheimer's disease and various other memory impairments. It is an alkaloid extracted from the bulbs and flowers of Galanthus nivalis, Galanthus caucasicus, Galanthus woronowii, and other members of the family Amaryllidaceae, such as Narcissus (daffodil), Leucojum aestivum (snowflake), and Lycoris including Lycoris radiata. It can also be produced synthetically.

Nutraceutical is a marketing term used to imply a pharmaceutical effect from a compound or food product that has not been scientifically confirmed or approved to have clinical benefits. In the United States, nutraceuticals are unregulated, existing in the same category as dietary supplements and food additives by the Food and Drug Administration (FDA), under the authority of the Federal Food, Drug, and Cosmetic Act.

<span class="mw-page-title-main">Adrafinil</span> Wakefulness promoting drug

Adrafinil, sold under the brand name Olmifon, is a wakefulness-promoting medication that was formerly used in France to improve alertness, attention, wakefulness, and mood, particularly in the elderly. It was also used off-label by individuals who wished to avoid fatigue, such as night workers or others who needed to stay awake and alert for long periods of time. Additionally, the medication has been used non-medically as a novel vigilance-promoting agent.

<span class="mw-page-title-main">Cannabidiol</span> Phytocannabinoid discovered in 1940

Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. As of 2022, clinical research on CBD included studies related to the treatment of anxiety, addiction, psychosis, movement disorders, and pain, but there is insufficient high-quality evidence that cannabidiol is effective for these conditions. CBD is also sold as a herbal dietary supplement promoted with unproven claims of particular therapeutic effects.

TrimSpa was a dietary supplement designed for weight loss, marketed by the company Goen Technologies and headed by Alexander Szynalski. The ephedra-based supplement was marketed by TrimSpa to help "stave off hunger", until ephedra was banned from the United States. TrimSpa's parent company, Goen Technologies, filed for bankruptcy protection in May 2008.

<span class="mw-page-title-main">Glucomannan</span> Chemical compound

Glucomannan is a water-soluble polysaccharide that is considered a dietary fiber. It is a hemicellulose component in the cell walls of some plant species. Glucomannan is a food additive used as an emulsifier and thickener. It is a major source of mannan oligosaccharide (MOS) found in nature, the other being galactomannan, which is insoluble.

<span class="mw-page-title-main">Phosphatidylserine</span> Chemical compound

Phosphatidylserine is a phospholipid and is a component of the cell membrane. It plays a key role in cell cycle signaling, specifically in relation to apoptosis. It is a key pathway for viruses to enter cells via apoptotic mimicry. Its exposure on the outer surface of a membrane marks the cell for destruction via apoptosis.

<span class="mw-page-title-main">Picamilon</span> Chemical compound

Picamilon is a drug formed by a synthetic combination of niacin and γ-aminobutyric acid (GABA). It was developed in the Soviet Union in 1969 and further studied in both Russia and Japan as a prodrug of GABA.

<span class="mw-page-title-main">Vincamine</span> Chemical compound

Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor, comprising about 25–65% of its indole alkaloids by weight. It can also be synthesized from related alkaloids.

ConsumerLab.com, LLC. is a privately held American company registered in White Plains, NY. It is a publisher of test results on health, wellness, and nutrition products. Consumer Labs is not a laboratory, but contracts studies to outside testing laboratories. It purchases dietary supplement products and other consumer goods directly from public storefronts and online retailers, contracts for testing by private laboratories, and publishes reports based on the results. It primarily derives revenue from the sale of subscriptions to its online publications, which are paywalled. Other sources of revenue include a proprietary certification program, licensing fees, contents re-publication license fees, and advertising.

<span class="mw-page-title-main">Herbal viagra</span> A class of herbal products said to treat erectile dysfunction

Herbal viagra is a herbal product advertised as treating erectile dysfunction. Many different products are advertised as herbal viagra, but with varying ingredients. No clinical trials or scientific studies support the effectiveness of any of these ingredients for the treatment of erectile dysfunction and some products have been found to contain drugs and other adulterants, and have been the subject of FDA and FTC warnings and actions to remove them from the market.

<span class="mw-page-title-main">Axona</span> Chemical compound

Axona was previously marketed as a medical food for the clinical dietary management of the impairment of metabolic processes associated with mild to moderate Alzheimer's disease. It is a proprietary formulation of fractionated palm kernel oil, a medium-chain triglyceride. Cericin, the company that makes Axona, states that during digestion, caprylic triglyceride is broken down into ketones, which provide an alternative energy source for the brain. Its use is based on the idea that the brain's ability to use its normal energy source, glucose, is impaired in Alzheimer's disease. Axona was first sold in March 2009.

<span class="mw-page-title-main">Sulfoaildenafil</span> Chemical compound

Sulfoaildenafil (thioaildenafil) is a synthetic drug that is a structural analog of sildenafil (Viagra). It was first reported in 2005, and it is not approved by any health regulation agency. Like sildenafil, sulfoaildenafil is a phosphodiesterase type 5 inhibitor.

Breast enlargement supplements are frequently portrayed as being a natural means to increase breast size, and with the suggestion that they are free from risk. The popularity of breast enlargement supplements stems from their heavy promotion toward women. Though there has been historical folklore about using herbs for breast enlargement, there is no scientific evidence to support the effectiveness of any breast enlargement supplement. At times, testimonials by companies have been faked. In the United States, both the Federal Trade Commission and the Food and Drug Administration have taken action against the manufacturers of these products for fraudulent practices. The Mayo Clinic advises that there may be serious drug interactions with their use.

Pre-workout is a generic term for a range of bodybuilding supplement products used by athletes and weightlifters to enhance athletic performance. Supplements are taken to increase endurance, energy, and focus during a workout. Pre-workout supplements contain a variety of ingredients such as caffeine and creatine, differing by capsule or powder products. The first pre-workout product entered the market in 1982, and since then the category has grown in use. Some pre-workout products contain ingredients linked to adverse effects. Although these products are not regulated, the Food and Drug Administration (FDA) warns consumers to be cautious when consuming them.

References

  1. 1 2 Office of the Commissioner (3 June 2019). "Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine". FDA. Retrieved 5 June 2019.
  2. ↑ "Vinpocetine in Dietary Supplements". FDA . February 22, 2023. Retrieved June 9, 2023.
  3. ↑ Zhang YS, Li JD, Yan C (January 2018). "An update on vinpocetine: New discoveries and clinical implications". European Journal of Pharmacology. 819: 30–34. doi: 10.1016/j.ejphar.2017.11.041 . PMC   5766389 . PMID   29183836.
  4. 1 2 Schmitt R (January 12, 2017). "Marketers exploit the aged with unproven brain-health claims". Newsweek . Retrieved January 18, 2016.
  5. ↑ Hank S (7 September 2016). "FDA rules vinpocetine not a legal dietary ingredient despite successful NDI filings". NutraIngredients. William Reed Business Media, England. Retrieved September 8, 2016.
  6. ↑ "FDA Concludes Vinpocetine Ineligible as a Dietary Ingredient". Nutraceuticals World. Rodman Media. September 20, 2016. Retrieved January 18, 2017.
  7. ↑ Schmitt R (February 3, 2017). "Dubious doses". Newsweek . Retrieved September 24, 2017.
  8. 1 2 3 4 Avula B, Chittiboyina AG, Sagi S, Wang YH, Wang M, Khan IA, et al. (March 2016). "Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States". Drug Testing and Analysis. 8 (3–4): 334–343. doi: 10.1002/dta.1853 . PMID   26426301.
  9. 1 2 3 4 Cohen PA (October 2015). "Vinpocetine: An Unapproved Drug Sold as a Dietary Supplement". Mayo Clinic Proceedings. 90 (10): 1455. doi: 10.1016/j.mayocp.2015.07.008 . PMID   26434971.
  10. 1 2 3 4 5 "Supplement Marketers Will Relinquish $1.4 Million to Settle FTC Deceptive Advertising Charges". Federal Trade Commission. U.S. Federal Trade Commission. July 8, 2015. Retrieved January 1, 2019.
  11. 1 2 Erickson BE (October 31, 2016). "Vinpocetine: drug or dietary supplement?". Chemical & Engineering News. 94 (43): 16–17. ISSN   0009-2347 . Retrieved December 28, 2018.
  12. ↑ Szatmari SZ, Whitehouse PJ (2003). "Vinpocetine for cognitive impairment and dementia". The Cochrane Database of Systematic Reviews. 2003 (1): CD003119. doi:10.1002/14651858.CD003119. PMC   8406981 . PMID   12535455.
  13. 1 2 Bereczki D, Fekete I (January 2008). "Vinpocetine for acute ischaemic stroke". The Cochrane Database of Systematic Reviews. 2008 (1): CD000480. doi:10.1002/14651858.CD000480.pub2. PMC   7034523 . PMID   18253980.
  14. ↑ McDaniel MA, Maier SF, Einstein GO (2003). ""Brain-specific" nutrients: a memory cure?". Nutrition. 19 (11–12): 957–975. doi:10.1016/S0899-9007(03)00024-8. PMID   14624946.
  15. ↑ National Toxicology Program (September 2013). "Chemical Information Review Document for Vinpocetine (CAS No. 42971-09-5)" (PDF). U.S. Department of Health and Human Services . Retrieved December 28, 2018.
  16. ↑ Office of the Commissioner (2019-06-03). "Statement on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine". FDA. Retrieved 2019-06-04.
  17. ↑ Hagiwara M, Endo T, Hidaka H (February 1984). "Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle". Biochemical Pharmacology. 33 (3): 453–457. doi:10.1016/0006-2952(84)90240-5. PMID   6322804.
  18. ↑ Jeon KI, Xu X, Aizawa T, Lim JH, Jono H, Kwon DS, et al. (May 2010). "Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism". Proceedings of the National Academy of Sciences of the United States of America. 107 (21): 9795–9800. doi: 10.1073/pnas.0914414107 . PMC   2906898 . PMID   20448200.
  19. ↑ Medina AE (June 2010). "Vinpocetine as a potent antiinflammatory agent". Proceedings of the National Academy of Sciences of the United States of America. 107 (22): 9921–9922. Bibcode:2010PNAS..107.9921M. doi: 10.1073/pnas.1005138107 . PMC   2890434 . PMID   20495091.
  20. ↑ Trejo F, Nekrassov V, Sitges M (August 2001). "Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings". Brain Research. 909 (1–2): 59–67. doi:10.1016/S0006-8993(01)02621-X. PMID   11478921. S2CID   38990597.
  21. ↑ French JM, King MD, McDougal OM (May 2016). "Quantitative Determination of Vinpocetine in Dietary Supplements". Natural Product Communications. 11 (5): 607–609. doi:10.1177/1934578X1601100512. PMC   5345962 . PMID   27319129.
  22. 1 2 McGrory K (July 9, 2015). "Tampa diet supplement firm pays $1.4 million settlement over 'brain power' pill claims". Tampa Bay Times . Retrieved January 1, 2019.
  23. ↑ Hall H (September 18, 2012). "Procera AVH: A Pill to Restore Memory". Science Based Medicine . Retrieved January 1, 2019.
  24. 1 2 3 4 Almada B (July 6, 2015). "False claims for brain supplement draw $152 million penalty from FTC". Orange County Register . Retrieved January 1, 2019.
  25. 1 2 3 4 "Procera AVH Marketers Can Forget About Claiming to Reverse Memory Loss". National Law Review . July 30, 2015. Retrieved 1 January 2019.
  26. 1 2 3 Myers S (July 8, 2015). "Memory Supplement Marketers Settle FTC Case for $150M". Natural Products Insider. Retrieved 1 January 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.